Elan Corp

Elan Corp maintains a strong liquidity position with JPY 6.85 billion in cash and equivalents, representing 26% of total assets. The company's liquidity FPT (free cash flow to total liabilities) stands at 18.7%, well above the industry median of 12.3% for healthcare services firms. The current ratio of 1.68 indicates sufficient short-term liquidity to cover obligations. Profitability metrics show Elan Corp outperforming industry benchmarks. Return on equity (ROE) of 19.16% exceeds the sector median of 14.2%, while return on assets (ROA) of 10.53% surpasses the 8.1% industry average. Operating margin of 7.7% (JPY 4.27 billion operating income on JPY 55.45 billion revenue) is 1.8 percentage points above the sector median. Geographically, Elan Corp derives 100% of revenue from Japan, with no disclosed segmental breakdown. The company's business model is concentrated in nursing care facilities, hospitals, and elderly care institutions, with no material diversification into other healthcare services or international markets. Growth projections indicate 9.1% revenue growth to JPY 60.5 billion in the current fiscal year, with analysts forecasting JPY 52.90 EPS compared to actual JPY 45.77. This represents 15.6% EPS growth, outpacing the 8.4% sector median. Historical revenue growth has averaged 4.2% annually over the past five years. Risk assessment shows low liquidity and dilution risk. The company has no immediate filing-based flags for liquidity stress or dilution. Debt-to-equity ratio of 0.06 is significantly below the sector median of 0.32. No dilution sources were identified in filings, with shares outstanding remaining unchanged at 60.48 million for both basic and diluted shares. Recent events include the Q4 2023 earnings release showing revenue growth to JPY 55.45 billion and EPS of JPY 45.77. The company has not issued new shares in the past 12 months, and no material regulatory changes have been disclosed that would impact its nursing care business model.